The CSR timeline challenge
Clinical Study Reports are among the most time-intensive documents in regulatory writing. A single CSR can take six weeks or more for the initial draft alone — and that timeline assumes experienced writers with ready access to all source materials.
The pressure is mounting. Sponsors want faster submissions. CROs need to deliver more efficiently. And writers are caught between compressing timelines and maintaining the quality regulators expect.
Where the time actually goes
When you break down a typical CSR drafting timeline, the bottleneck is rarely scientific judgment. Most of the time is consumed by mechanical tasks: locating the right sections in a 200-page protocol, cross-referencing statistical outputs across dozens of TFL pages, reformatting tables, and stitching narratives that are consistent across sections.
Non-data-driven sections (ICH E3 sections 1 through 9) require careful rewriting from the trial protocol. Writers must ensure that study objectives, inclusion and exclusion criteria, and endpoint definitions are accurately captured without omission. Data-driven sections (section 10 onward) demand consistent interpretation of statistical outputs — often across multiple study objectives, each with its own set of tables.
What changes with AI-assisted drafting
Asthra reduces this timeline by handling the mechanical work: retrieving the right content from the right source document, generating section drafts aligned to the template structure, and maintaining consistency across outputs.
Writers define which source documents and which specific sections, tables, or images should inform each part of the CSR. Asthra retrieves the relevant content and generates a structured first draft — section by section or all at once.
The result is an initial draft generated in approximately 30 minutes, covering both data-driven and non-data-driven sections. Writers then focus their time on review, interpretation, and refinement rather than on the initial assembly work.
What this means for teams
Faster first drafts do not mean less rigor. They mean writers spend their expertise where it matters most — on clinical interpretation, consistency checks, and regulatory judgment — rather than on copy-paste and reformatting.
For CROs, this translates to more predictable delivery timelines. For sponsors, it means submissions can move forward without the documentation bottleneck that historically delays regulatory filings.
The traceability advantage
Speed without traceability would be a liability in regulated environments. Asthra addresses this by providing two levels of traceability: provenance (which source file and section was referenced for each output) and sentence-level citations (file name, page number, and text snippet for each generated sentence).
This means reviewers and auditors can verify any claim in the draft back to its source — something that is often harder to achieve with traditional manual drafting.
Looking ahead
CSR timelines are compressing across the industry. The question is whether teams compress them by asking writers to work faster under pressure, or by removing the mechanical effort that consumes most of their time. AI-assisted drafting offers the second path — faster timelines with better traceability, not despite the speed, but because of the approach.